Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06477133 · ClinicalTrials.gov registry record · Phase 4
Magnesium Sulfate as an Adjunctive Analgesic in Prostate Surgery
A Phase 4 study of Prostatectomy, sponsored by NYU Langone Health.
- Active
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT06477133 is a Phase 4 study of Prostatectomy that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 68 participants, below the 114-participant average among 4 other Prostatectomy trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06477133, a Phase 4 study of Prostatectomy, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to determine if receiving magnesium sulfate as an adjunctive analgesic for prostate surgery is effective in reducing pain. Subjects will be randomized to receive magnesium or not receive it, as part of a standardized general anesthetic for prostate surgery. The primary objective is to demonstrate improved pain scores in patients receiving magnesium sulfate as an adjunctive analgesic during surgery. Secondary objectives include demonstrating reduced requirements for other opioids, reduced postoperative shivering, improved discharge home and adequate neuromuscular blockade reversal, measured by quantitative train of four monitoring.
Conditions Studied
Interventions
- DRUG Magnesium sulfate
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2024-06-04 |
| Est. Completion | 2026-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06477133
The ClinicalTrials.gov registry entry for NCT06477133 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 114-participant average among 4 other Prostatectomy trials with a reported enrollment target (40% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostatectomy appearing as the primary indexed condition, and to 1 intervention - of which Magnesium sulfate is the first listed.
NCT06477133 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06477133 about?
NCT06477133 is a clinical study titled "Magnesium Sulfate as an Adjunctive Analgesic in Prostate Surgery". The purpose of this clinical trial is to determine if receiving magnesium sulfate as an adjunctive analgesic for prostate surgery is effective in reducing pain. Subjects will be randomized to receive magnesium or not receive it, as part of a standardized general anesthetic for prostate surgery. The ...
What is the current status of trial NCT06477133?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2024-06-04. Estimated completion is 2026-06.
What conditions does trial NCT06477133 study?
This clinical trial studies the following conditions: Prostatectomy.
What interventions are being tested in trial NCT06477133?
The interventions under investigation include: Magnesium sulfate (DRUG).
Who is sponsoring clinical trial NCT06477133?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06477133 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostatectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TAP-patients With Robotic Assisted Lap Prostatectomy
COMPLETED · Phase 4
-
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
RECRUITING · Phase 3
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.